Prime Medicine (PRME) Other Non Operating Income (2021 - 2026)
Prime Medicine posted quarterly Other Non Operating Income of $51000.0 for Q1 2026, up 37.84% year-on-year from $37000.0 in Q1 2025, and up 4.08% on a QoQ basis from $49000.0 in Q4 2025.
Prime Medicine (PRME) has 6 years of Other Non Operating Income data on file, last reported at $51000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 37.84% year-over-year to $51000.0; the trailing twelve-month figure through Mar 2026 stood at $162000.0 (up 350.0% YoY), and the FY2025 full-year result was $148000.0, up 260.98% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $51000.0, up from $49000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.1 million in Q1 2023 and bottomed at -$83000.0 in Q3 2024.
- The 5-year median for Other Non Operating Income is $43000.0 (2023), against an average of $265294.1.
- The widest annual swing landed in 2022, when Other Non Operating Income soared 72900.0%; it then sank 293.02% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $926000.0 in 2022, then tumbled by 84.02% to $148000.0 in 2023, then plunged by 70.95% to $43000.0 in 2024, then increased by 13.95% to $49000.0 in 2025, then climbed by 4.08% to $51000.0 in 2026.
- The last three Other Non Operating Income figures came in at $51000.0 (Q1 2026), $49000.0 (Q4 2025), and $44000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Prime Medicine | 601.24 Mn | 601.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 926,000.00 |
| Sep 30, 2022 | 728,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | -1,000.00 |